BioMedicaal Asia 2008 ŒöŽ®ƒTƒCƒg
°Ñ¥[¥Ó½Ð


supported by

 A Star Logo

BioOne Logo

EDB Logo

SECB

held in

Uniquely singapore logo

international marketing partner

     

endorsed by

other related events

 






ijµ{


15 April 2008, Tuesday
16 April 2008, Wednesday

last modified: 11/01/2008 10:43:00 (GMT)

15 April 2008, Tuesday
08.00
Registration and refreshments
 
08.30
Organizer's welcome remarks
 
08.45
Guest-of-honour address Lim Hng Kiang Minister Ministry of Trade & Industry, Singapore
 
08.55
Chairman's welcome remarks
 
09.00
Global keynote address and executive interview: The evolving biomedical science and industry
  • Market trends and drivers of the biomedical industry and crystal balling future growth
  • Emerging biomedical innocation from Asia and its impact
  • The evolution of the global biotech capital market: Where and how does Asia fit into the equation
 
10.00
Morning refreshments, BioMedical Technology Showcase session and combined speed networking
 
IDENTIFYING THE CHALLENGES AND OPPORTUNITIES IN BIOINFORMATICS IN ASIA
11.10
Bioinformatics host country opening keynote: Examining the Bioinformatics industry in Singapore and its role in pharma and biotech industry moving forwards 2008- 2009
  • The evolution and growth of the bioinformatics industry in Singapore
  • The role of the BII and the part BII plays in supporting the development of pharma and biotech industry
  • The challenges and opportunities in the future
 
11.40
ASEAN regulatory & policy maker roundtable discussion on bioinformatics developments in their respective countries
  • What are ASEAN initiatives put in place to encourage the sharing of biomedical information?
  • What are some of the challenges faced in using bioinformatics?
  • Individual country discussion
 
12.30
Afternoon refreshment, showcase session and speed networking
 
BRIDGING THE GAP BETWEEN LIFE SCIENCE & IT
14.00
Effectively developing an informatics system to meet new business drivers in the 21st Century
  • Identifying your main business drivers and tailor your informatics systems to meet them
  • Effectively re-engineering your informatics systems to do things smarter and cheaper
  • Case study on Astra Zeneca
 
14.30
Designing next generation data architecture in preparation
  • Developing a data architecture with time, space, financial and quality benefits
  • Incorporating flexibility in your data architecture to cope with changing demands of operational business units
  • Case study on KOBIC
 
15.00
Bio21: Molecular Medicine Informatics Model – A unique clinical research data linkage platform
  • Developing a platform that provides researchers access to data from disparate exsisting database
  • Successfully linking publicly available research and genetic profiling data
  • Case study on Molecular Medicine Informatics Model
 
15.30
Afternoon refreshments and showcase session
 
NEXT GENERATION BUSINESS MODELS & OUTSOURCING
16.30
Implementing IT solutions for Biomarkers in Bio-Pharmaceutical R&D
  • The move to incorporate biomarker concepts throughout R&D and building significant molecular imaging capabilities
  • What are the IT standards and architectures that support incorporation of imaging biomarkers into drug discovery and clinical development?
  • Challenges related to integration of imaging biomarker data with clinical and genotypic data
 
17.00
Successfully utilizing bioinformatics, imaging and data sharing technologies in biomarker R&D
  • Identifying new technologies for usage in biomarker R&D
  • The role bioinformatics, imaging and data sharing can enhance biomarker research
  • Case study on Actis Biologics
 
17.30
Close of conference day one
 
19.00
BioMedical Industry Awards & Gala Dinner
 

16 April 2008, Wednesday
08.00
Registration and refreshments
 
08.45
Chairman's opening remarks
 
SECURITY, STANDARDS AND INTEROPERABILITY ISSUES
09.00
Addressing recent security issues in pharmaceutical/bioinformatics data management
  • Identifying the security concerns of integrating, transferring and managing huge data sets across regional centers
  • Strategies to ensure and prevent breach of data security
  • Case study on I2R
 
09.30
Interoperability & standards: Progressing towards an industry architecture in clinical research and translational medicine - The BRIDG Model
  • The implementation of Biomedical Research Integrated Domain Group (BRIDG) model project
  • Determining the basis for harmonization among standards within the clinical research domain, biomedical/clinical research and healthcare
  • Applications in the Life Science IT industry
 
10.00
The importance of MHC binding and in silico prediction
  • Overview of cell-mediated immune response and importance of MHC binding
  • Use of state-of-the-art computational algorithms to model/predict MHC binding events
  • Relevance to the design of vaccines and therapeutics
 
10.30
Morning refreshments and showcase session
 
11.00
Effectively creating the IT infrastructure for enhanced data management in electronic health/medical records – Kameda Medical Centre
  • Implementing innovative technologies that can help to improve the quality and reduce costs associated with computerizing records
  • Creating a system that integrates data used by nearly 30 hospitals in Japan to assist in managing the workflow of patient care delivery at their facilities
  • Case study on Kameda Medical Centrefs KAI system
 
SUCCESSFUL DATA INTEGRATION & TRANSFER
11.30
Addressing the need to develop an informatics system that integrate data systems in a clinical/university framework – Vienna General Hospital
  • The implementation of General Hospital Information Management  (Allgemeines Krankenhaus Information Management) AKIM project
  • The ongoing implementation of a gene expression (micro-array chips) platform
  • Discussion of the solutions envisaged to ensure flexibility, user-friendliness and modularity of the bioinformatics platform
 
12.00
Addressing the need to develop Electronic Data Capture as a cost effective integrated enterprise solution in clinical trials
  • Developing a flexible Electronic Data Capture solution that will enhance speed and productivity gains of clinicial trials
  • Successfully yielding maximum gains from your EDC
  • Case study on Merck
 
12.30
Network luncheon
 
14.00
Innovation Biotech Showcase

It will offer technology companies seeking Bioinformatics opportunities an exceptional platform to showcase their innovation software and hardware technologies to a targeted group of industry professionals

 
14.30
Innovative Biotech Showcase

It will offer technology companies seeking Bioinformatics opportunities an exceptional platform to showcase their innovation software and hardware technologies to a targeted group of industry professionals

 
15.00
Panel Discussion: Identifying the challenges faced in implementing successful data integration and transfer and the role of bioinformatics in meeting these challenges
  • What are some of the challenges faced by organizations in data integration and transfer?
  • How can these challenges be met in a cost efficient manner?
  • The role of bioinformatics in helping to meet these challenges
 
15.30
Translational medicine: a bioinformatics perspective
  • How to integrate and transfer genomic data from different ethnic groups in Asia
  • How to centrally manage and share data through different data centres efficiently
  • The various roles of bioinformatics from bench to bedside and from western countries to Oriental markets
 
16.00
Afternoon refreshments and showcase session
 
INNOVATION AND TECHNOLOGICAL ADVANCEMENTS
16.30
Successfully developing informatics solutions to meet drug discovery needs
  • Developing and utilizing informatics tools to meet current challenges in drug discovery and development
  • A framework based approach to develop informatics platforms to integrate multiple applications and data sources
  • Case study on Lily
 
17.00
Developing of enabling Informatics Technology in support of the development of drug candidates
  • Developing an informatics systems that integrate the information supplied from materials management system, laboratory IMS, data archival system and data documentation system
  • Determining how higher sample throughput has led to integration of various analytical and informatics solution
  • Case study on Pfizer
 
18.00
Close of conference day 2
 
18.30
Cocktail Party Finale at Singapore Flyer
 
conferences featured
¤éµ{
4¤ë14¤é(¤@)¡B4¤ë17¤é(¥|)


4¤ë15¤é(¤G) AM8:00¡ãPM5:30
¥D·|ij²Ä¤@¤Ñ

4¤ë16¤é(¤T)
¥D·|ij²Ä¤G¤Ñ

¦Uijµ{
> BioManufacturing Asia
> BioTherapeutics Asia
> BioLicensing Asia
> BioInvest Asia
©Terrapinn Ltd. MMVII
¤¤¤å©x¤èºô¯¸Àç¹B¡GTerrapinn ¥N²z°Ó ¤é°ÓÀô²y°T®§¦³­­¤½¥q